Importantly, it has been revealed that MMP-2 expression is positively controlled by Smad2 whilst MMP-9 is modulated via NF-κB p65/p50 transcription signaling in tumor tissues and cells of CRC (Muscella et al., 2020; Napoli et al., 2020). The gene discussed is MMP9; the disease is neoplasm.